Physician profile
Dharam Mann
NPI 1063463099
$15,112.50
in general payments reported to CMS, 2019-2025
17 companies · $404 in 2025
The $404 reported for 2025 was more than what 75% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $833 · 2021: $960 · 2022: $445 · 2023: $618 · 2024: $594 · 2025: $404.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,616.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Foundation Fusion Solutions, LLC | $10,090.00 | 2019 | |
| Abbott Laboratories | $1,961.53 | 2019-2025 | Proclaim, Eterna, Octrode |
| Medtronic USA, INC. | $685.07 | 2019-2020 | |
| Medtronic, INC. | $625.54 | 2021-2025 | Interstim, Synchromedii |
| Boston Scientific Corporation | $296.67 | 2020-2022 | |
| Vertiflex, INC. | $238.25 | 2019 | |
| Stimwave Technologies Incorporated | $220.34 | 2019 | |
| Axonics, INC. | $195.89 | 2020-2021 | |
| Olympus America INC. | $177.44 | 2025 | Itind System |
| Vertos Medical, INC. | $139.55 | 2022 | |
| Relievant Medsystems, INC. | $119.60 | 2021 | |
| Painteq LLC | $115.73 | 2023 | Painteq |
| Procept Biorobotics Corporation | $99.29 | 2023 | Aquabeam Robotic System |
| Nuvasive, INC. | $69.33 | 2020 | |
| Spinefrontier, INC. | $62.83 | 2025 | Sijfuse, Inspan, Nanofuse |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linus Health, INC. | $15.44 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$22,494,361.70 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dharam Mann listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.